By Taylor Mixides (Drug Target Review)2023-04-10T16:00:44
A newly developed drug displays potential in treating both heart failure and the related sleep apnea.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2025-05-08T10:38:52
Sponsored by Takara Bio USA
2023-03-20T13:41:33
Sponsored by Bio-Techne
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2025-05-14T14:30:00
Sponsored by Abzena
2023-07-04T10:05:58
Sponsored by Revvity
Site powered by Webvision Cloud